ACADIA PHARMACEUTICALS INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $31.5M | $3.6M | $71.8M | $26.7M | $19.0M | $32.8M | $33.4M | $16.6M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | $271.0K | — | — | $229.0K | — | — | $242.0K |
| Amortization | — | $2.7M | — | — | $2.7M | — | — | $5.3M |
| Stock-Based Compensation | — | $14.7M | — | — | $11.4M | — | — | $14.8M |
| Net Cash from Operating Activities | $100.8M | $34.0M | $74.3M | $64.0M | $20.3M | $63.2M | $25.0M | $29.1M |
| Investing Activities | ||||||||
| Capital Expenditures | $5.1M | $5.2M | $388.0K | $297.0K | $0 | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $66.3M | — | — | $-124.0M | — | — | $-14.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $4.2M | — | — | $1.8M | — | — | $1.0M |
| Net Change in Cash | — | $104.5M | — | — | $-101.9M | — | — | $16.1M |
| Free Cash Flow | $95.7M | $28.8M | $73.9M | $63.7M | $20.3M | — | — | — |